Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Editas Medicine (EDIT) Reports Q4 Loss of $1.00/sh
February 25, 2021 7:55 AM ESTEditas Medicine (NASDAQ: EDIT) reported Q4 EPS of ($1.00), versus ($0.74) reported last year. Revenue for the quarter came in at $11.4 million, versus $12.3 million reported last year.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
... More